Olezarsen
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia. Reply.
Journal: The New England journal of medicine
Published: December 30, 2025
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia.
Journal: The New England journal of medicine
Published: December 30, 2025
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia.
Journal: The New England journal of medicine
Published: December 30, 2025
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 American Heart Association Scientific Sessions.
Journal: Current atherosclerosis reports
Published: December 02, 2025
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk.
Journal: The New England journal of medicine
Published: November 10, 2025
Lessons from recent clinical trials for the prevention of acute pancreatitis in chylomicronemia syndromes.
Journal: Current opinion in endocrinology, diabetes, and obesity
Published: November 10, 2025
Olezarsen in moderate hypertriglyceridemia: The Essence-TIMI 73b trial.
Journal: Med (New York, N.Y.)
Published: October 20, 2025
Small RNA or oligonucleotide drugs and challenges in evaluating drug-drug interactions.
Journal: Frontiers in pharmacology
Published: October 07, 2025
Approach to the Adult Patient with Chylomicronemia.
Journal: The Journal of clinical endocrinology and metabolism
Published: October 01, 2025
Olezarsen and Post-prandial Triglyceride Levels.
Journal: European journal of preventive cardiology
Published: September 29, 2025
Last Updated: 02/24/2026